Covance is a comprehensive, biopharmaceutical drug development services company with preclinical and clinical research operations across the globe. en-us Copyright 2010 Covance Inc. All rights reserved. CRO for Drug Development Services http://www.covance.com/images/img_gfx/covance.gif 175 37 http://www.covance.com/ Covance and BioPontis Alliance Collaborate to Bridge Drug Development Gap Thurs, 2 Feb 2012 10:06:32 EST Covance Reports Fourth Quarter Revenue of $532M, GAAP EPS of $0.35, Pro Forma EPS of $0.73, and Adjusted Net Orders of $759M Wed, 25 Jan 2012 16:12:30 EST Covance Board Authorizes $300 Million Stock Buyback Wed, 25 Jan 2012 16:08:01 EST Covance, Inserm Transfert SA, and Inserm Transfert Initiative Enter Four-Year Scientific Agreement Thu, 12 Jan 2012 4:00:34 EST